FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/10/2023
Voltar para busca
Dado oficial do USPTO
EXPLORASPHERE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EXPLORASPHERE
ST13
US500000079350385Classe
5, 9, 10, 35, 38, 42
Pedido
79350385
Registro
7070826
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
04/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 35, 38, 42
Data de depósito
23/02/2022
Data de registro
06/06/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/06/2023
Última transação
06/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
HSU, FONG
Unidade examinadora
O20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 35Classe 38Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Classe 9
downloadable software for management of patient medical information
Classe 10
Medical and surgical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical and surgical apparatus and instruments for diagnosing and treating dermatological diseases; medical and surgical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical and surgical apparatus and instruments for diagnosing and treating central nervous system diseases; medical and surgical apparatus and instruments for diagnosing and treating gastro-intestinal diseases; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; medical and surgical apparatus and instruments for use in hematology and in tissue and organ transplantation; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of eye diseases and conditions; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of heart rhythm disorders; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of immune system related diseases and disorders; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of kidney diseases; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of diabetes; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of hypertension; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of skin disorders; medical and surgical apparatus and instruments for use in urology; medical and surgical apparatus and instruments for ophthalmological use; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of cancer and tumors; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of allergies; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of bone diseases; medical and surgical apparatus and instruments for the diagnosisprevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical and surgical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical and surgical apparatus and instruments for diagnostic radiopharmaceutical use; medical and surgical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical and surgical use; medical apparatusinfusion and injection devices for administering drugs; medical and surgical apparatus and instruments for introducing pharmaceutical preparations into the human body
Classe 35
Advertisingmarketing and promotional services relating to pharmaceuticals
Classe 38
Providing online chat rooms and electronic bulletin boards for the transmission of messages among users in the fields of healthcarepharmaceuticalsdevelopments therein; Transmission of information in the field of pharmaceutical preparations; broadcasting servicestransmission of advertising programs and media advertising communications via digital communication networks
Classe 42
Scientific research services; Hosting websites featuring educational content in the field of health
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/09/2023
FIMP
FINAL DISPOSITION PROCESSED
12/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/03/2023
PUBO
PUBLISHED FOR OPPOSITION
21/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2023
RFNP
REFUSAL PROCESSED BY IB
07/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/01/2023
RFRR
REFUSAL PROCESSED BY MPU
13/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/12/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/12/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2022
CNRT
NON-FINAL ACTION WRITTEN
01/11/2022
DOCK
ASSIGNED TO EXAMINER
31/10/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/09/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
29/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/09/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXPLORASPHERE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.